These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28513756)

  • 1. Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1-42).
    Sum TH; Sum TJ; Collins S; Galloway WRJD; Twigg DG; Hollfelder F; Spring DR
    Org Biomol Chem; 2017 May; 15(21):4554-4570. PubMed ID: 28513756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory activities of biflavonoids against amyloid-β peptide 42 cytotoxicity in PC-12 cells.
    Sasaki H; Kitoh Y; Tsukada M; Miki K; Koyama K; Juliawaty LD; Hakim EH; Takahashi K; Kinoshita K
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2831-3. PubMed ID: 26004578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation.
    Windsor PK; Plassmeyer SP; Mattock DS; Bradfield JC; Choi EY; Miller BR; Han BH
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring biflavonoids with amyloid β aggregation inhibitory activity for development of anti-Alzheimer agents.
    Sirimangkalakitti N; Juliawaty LD; Hakim EH; Waliana I; Saito N; Koyama K; Kinoshita K
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1994-1997. PubMed ID: 31138471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies.
    Mohamed T; Rao PPN
    Eur J Med Chem; 2017 Jan; 126():823-843. PubMed ID: 27951490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systems.
    Navarro S; Carija A; Muñoz-Torrero D; Ventura S
    Eur J Med Chem; 2016 Oct; 121():785-792. PubMed ID: 26608003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity.
    Li L; Chen M; Jiang FC
    Bioorg Med Chem; 2016 Apr; 24(8):1853-65. PubMed ID: 26972922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal Chemistry Focusing on Aggregation of Amyloid-β.
    Sohma Y
    Chem Pharm Bull (Tokyo); 2016; 64(1):1-7. PubMed ID: 26726739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Aβ
    Xu P; Zhang M; Sheng R; Ma Y
    Eur J Med Chem; 2017 Feb; 127():174-186. PubMed ID: 28061347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiosemicarbazone modification of 3-acetyl coumarin inhibits Aβ peptide aggregation and protect against Aβ-induced cytotoxicity.
    Ranade DS; Bapat AM; Ramteke SN; Joshi BN; Roussel P; Tomas A; Deschamps P; Kulkarni PP
    Eur J Med Chem; 2016 Oct; 121():803-809. PubMed ID: 26232353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
    Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
    Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease.
    Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
    Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
    García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Ligand-Based NMR Screening Approach for the Identification and Characterization of Inhibitors and Promoters of Amyloid Peptide Aggregation.
    Dalvit C; Santi S; Neier R
    ChemMedChem; 2017 Sep; 12(17):1458-1463. PubMed ID: 28722296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory activity of the synthetic C-C biflavonoids.
    Park H; Kim YH; Chang HW; Kim HP
    J Pharm Pharmacol; 2006 Dec; 58(12):1661-7. PubMed ID: 17331331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted Influences of Melanin-Like Particles on Amyloid-beta Aggregation.
    Song H; Kim Y; Kim I; Kim YK; Kwon S; Kang K
    Chem Asian J; 2020 Jan; 15(1):91-97. PubMed ID: 31778040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
    Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
    J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
    Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
    Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.